Molecular bases of hepatic fibrogenesis - Genetic and therapeutical implications in chronic viral C hepatitis

Romanian Journal of Morphology and Embryology

Volumn 49, Issue 1, 2008, Pages 21-25

  Rogoveanu, I ^a   Sǎndulescu, Daniela Larisa ^a   Gheonea, D I ^a   Ciurea, T ^a   Comǎnescu, Violeta ^b  

^a UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

^b Emergency County Hospital of Craiova   (Romania)

Author keywords

Antiviral therapy; Chronic viral C hepatitis; Fibrogenesis

Indexed keywords

HEPATITIS C VIRUS;

CELL PROLIFERATION; DISEASE COURSE; GENETICS; HEPATITIS C; HUMAN; LIVER CELL; LIVER CIRRHOSIS; PHYSIOLOGY; REVIEW; STEM CELL;

CELL PROLIFERATION; DISEASE PROGRESSION; HEPATITIS C, CHRONIC; HEPATOCYTES; HUMANS; LIVER CIRRHOSIS; STEM CELLS;

EID: 51449093377     PISSN: 12200522     EISSN: 20668279     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Ray Kim W., Global epidemiology and burden of hepatitis C, Microbes Infect, 2002, 4(12):1219-1225.
2. Dienstag J. L., McHutchison J. G., American Gastroenterological Association technical review on the management of hepatitis C, Gastroenterology, 2006, 130(1):231-264; quiz 214-217.
3. Blanc J. F., Bioulac-Sage P., Balabaud C., Desmoulière A., Investigation of liver fibrosis in clinical practice, Hepatol Res, 2005, 32(1):1-8.
4. Lau D. T., Luxon B. A., Xiao S. Y., Beard M. R., Lemon S. M., Intrahepatic gene expression profiles and alpha-smooth muscle actin patterns in hepatitis C virus induced fibrosis, Hepatology, 2005, 42(2):273-281.
5. Carpino G., Franchitto A., Morini S., Corradini S. G., Merli M., Gaudio E., Activated hepatic stellate cells in liver cirrhosis. A morphologic and morphometrical study, Ital J Anat Embryol, 2004, 109(4):225-238.
6. Levy M. T., McCaughan G. W., Marinos G., Gorrell M. D., Intrahepatic expression of the hepatic stellate cell marker fibroblast activation protein correlates with the degree of fibrosis in hepatitis C virus infection, Liver, 2002, 22(2):93-101.
7. Carpino G., Morini S., Ginanni Corradini S., Franchitto A., Merli M., Siciliano M., Gentili F., Onetti Muda A., Berloco P., Rossi M., Attili A. F., Gaudio E., Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation, Dig Liver Dis, 2005, 37(5):349-356.
8. Núñez O., Fernández-Martínez A., Majano P. L., Apolinario A., Gómez-Gonzalo M., Benedicto I., López-Cabrera M., Boscá L., Clemente G., García-Monzón C., Martín-Sanz P., Increased intrahepatic cyclooxygenase 2, matrix metalloproteinase 2, and matrix metalloproteinase 9 expression is associated with progressive liver disease in chronic hepatitis C virus infection: role of viral core and NS5A proteins, Gut, 2004, 53(11):1665-1672.
9. Schulze-Krebs A., Preimel D., Popov Y., Bartenschlager R., Lohmann V., Pinzani M., Schuppan D., Hepatitis C virus-replicating hepatocytes induce fibrogenic activation of hepatic stellate cells, Gastroenterology, 2005, 129(1):246-258.
10. Tsamandas A. C., Syrokosta I., Thomopoulos K., Zolota V., Dimitropoulou D., Liava A., Coupoulou A. A., Siagris D., Petsas T., Karatza C., Gogos C. A., Potential role of hepatic progenitor cells expression in cases of chronic hepatitis C and their relation to response to therapy: a clinicopathologic study, Liver Int, 2006, 26(7):817-826.
11. Brooling J. T., Campbell J. S., Mitchell C., Yeoh G. C., Fausto N., Differential regulation of rodent hepatocyte and oval cell proliferation by interferon gamma, Hepatology, 2005, 41(4):906-915.
12. Lim R., Knight B., Patel K., McHutchison J. G., Yeoh G. C., Olynyk J. K., Antiproliferative effects of interferon alpha on hepatic progenitor cells in vitro and in vivo, Hepatology, 2006, 43(5):1074-1083.
13. 4/2-AAF injury. Histol Histopathol, 2002, 17(1):65-81.
14. Clouston A. D., Powell E. E., Walsh M. J., Richardson M. M., Demetris A. J., Jonsson J. R., Fibrosis correlates with a ductular reaction in hepatitis C: roles of impaired replication, progenitor cells and steatosis, Hepatology, 2005, 41(4):809-818.
15. Shin J. Y., Hur W., Wang J. S., Jang J. W., Kim C. W., Bae S. H., Jang S. K., Yang S. H., Sung Y. C., Kwon O. J., Yoon S. K., HCV core protein promotes liver fibrogenesis via up-regulation of CTGF with TGF-beta1, Exp Mol Med, 2005, 37(2):138-145.
16. Rigamonti C., Andorno S., Maduli E., Capelli F., Boldorini R., Sartori M., Gender and liver fibrosis in chronic hepatitis: the role of iron status, Aliment Pharmacol Ther, 2005, 21(12):1445-1451.
17. Ortiz V., Berenguer M., Rayón J. M., Carrasco D., Berenguer J., Contribution of obesity to hepatitis C-related fibrosis progression, Am J Gastroenterol, 2002, 97(9):2408-2414.
18. Collier J. D., Woodall T., Wight D. G., Shore S., Gimson A. E., Alexander G. J., Predicting progressive hepatic fibrosis stage on subsequent liver biopsy in chronic hepatitis C virus infection, J Viral Hepat, 2005, 12(1):74-80.
19. Cholet F., Nousbaum J. B., Richecoeur M., Oger E., Cauvin J. M., Lagarde N., Robaszkiewicz M., Gouérou H., Factors associated with liver steatosis and fibrosis in chronic hepatitis C patients, Gastroenterol Clin Biol, 2004, 28(3):272-278.
20. Wang H., Mengsteab S., Tag C. G., Gao C. F., Hellerbrand C., Lammert F., Gressner A. M., Weiskirchen R., Transforming growth factor-beta1 gene polymorphisms are associated with progression of liver fibrosis in Caucasians with chronic hepatitis C infection, World J Gastroenterol, 2005, 11(13):1929-1936.
21. Okamoto K., Mimura K., Murawaki Y., Yuasa I., Association of functional gene polymorphisms of matrix metalloproteinase (MMP)-1, MMP-3 and MMP-9 with the progression of chronic liver disease, J Gastroenterol Hepatol, 2005, 20(7):1102-1108.
22. Chen L., Borozan I., Feld J., Sun J., Tannis L. L., Coltescu C., Heathcote J., Edwards A. M., McGilvray I. D., Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection, Gastroenterology, 2005, 128(5):1437-1444.
23. Asselah T., Bièche I., Laurendeau I., Paradis V., Vidaud D., Degott C., Martinot M., Bedossa P., Valla D., Vidaud M., Marcellin P., Liver gene expression signature of mild fibrosis in patients with chronic hepatitis C, Gastroenterology, 2005, 129(6):2064-2075.
24. Giannelli G., Bergamini C., Marinosci F., Fransvea E., Napoli N., Maurel P., Dentico P., Antonaci S., Antifibrogenic effect of IFN-alpha2b on hepatic stellate cell activation by human hepatocytes, J Interferon Cytokine Res, 2006, 26(5):301-308.
25. Iredale J. P., Hepatic stellate cell behavior during resolution of liver injury, Semin Liver Dis, 2001, 21(3):427-436.
26. Poynard T., Leroy V., Cohard M., Thevenot T., Mathurin P., Opolon P., Zarski J. P., Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration, Hepatology, 1996, 24(4):778-789.
27. Cammà C., Di Bona D., Schepis F., Heathcote E. J., Zeuzem S., Pockros P. J., Marcellin P., Balart L., Alberti A., Craxì A., Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C: a meta-analysis of individual patient data, Hepatology, 2004, 39(2):333-342.
28. Poynard T., Yuen M. F., Ratziu V., Lai C. L., Viral hepatitis C, Lancet, 2003, 362(9401):2095-2100.
29. Elrick L. J., Leel V., Blaylock M. G., Duncan L., Drever M. R., Strachan G., Charlton K. A., Koruth M., Porter A. J., Wright M. C., Generation of a monoclonal human single chain antibody fragment to hepatic stellate cells-a potential mechanism for targeting liver anti-fibrotic therapeutics, J Hepatol, 2005, 42(6):888-896.